S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)

agilon health (AGL) Stock Forecast, Price & News

$18.43
+0.04 (+0.22%)
(As of 09/22/2023 ET)
Compare
Today's Range
$18.17
$18.84
50-Day Range
$16.70
$20.14
52-Week Range
$15.00
$29.44
Volume
1.95 million shs
Average Volume
2.83 million shs
Market Capitalization
$7.47 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.39

agilon health MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
48.6% Upside
$27.39 Price Target
Short Interest
Bearish
13.30% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.63mentions of agilon health in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.48 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.14) to $0.10 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.68 out of 5 stars

Medical Sector

840th out of 968 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

7th out of 7 stocks


AGL stock logo

About agilon health (NYSE:AGL) Stock

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

AGL Price History

AGL Stock News Headlines

Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
The Latest Analyst Ratings for Agilon Health
J.P. Morgan Remains a Buy on Agilon Health (AGL)
Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
agilon health Reports Second Quarter 2023 Results
Truist Financial Remains a Buy on Agilon Health (AGL)
agilon health: A Hold Until Margins Are Improved
Stifel Nicolaus Reaffirms Their Buy Rating on Agilon Health (AGL)
Agilon Health (AGL) Receives a Buy from Stifel Nicolaus
See More Headlines
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for agilon health and its competitors with MarketBeat's FREE daily newsletter.

AGL Company Calendar

Last Earnings
8/03/2023
Today
9/22/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
747
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$27.39
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$22.50
Forecasted Upside/Downside
+49.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-106,550,000.00
Pretax Margin
-2.38%

Debt

Sales & Book Value

Annual Sales
$2.71 billion
Book Value
$2.53 per share

Miscellaneous

Free Float
390,885,000
Market Cap
$7.43 billion
Optionable
Not Optionable
Beta
1.00
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Steven Jackson Sell (Age 57)
    Pres, CEO & Director
    Comp: $1.29M
  • Mr. Timothy S. Bensley (Age 63)
    Chief Financial Officer
    Comp: $831.31k
  • Mr. Girish Venkatachaliah (Age 49)
    Chief Technology Officer
    Comp: $655.04k
  • Mr. Ben Shaker (Age 40)
    Chief Markets Officer
    Comp: $715.5k
  • Mr. Veeral  DesaiMr. Veeral Desai (Age 42)
    Chief Strategy & Devel. Officer
    Comp: $667.58k
  • Mr. Timothy Gertsch (Age 37)
    VP, Controller & Chief Accounting Officer
  • Mr. Matthew Dale Gillmor CFA
    VP of Investor Relations
  • Ms. Denise Zamore
    Chief Legal Officer & Sec.
  • Ms. Claire Mulhearn
    Chief Communications & Public Affairs Officer
  • Mr. Mat Varghese
    Chief People Officer













AGL Stock - Frequently Asked Questions

Should I buy or sell agilon health stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AGL shares.
View AGL analyst ratings
or view top-rated stocks.

What is agilon health's stock price forecast for 2023?

7 Wall Street research analysts have issued 1 year price objectives for agilon health's shares. Their AGL share price forecasts range from $22.50 to $32.00. On average, they predict the company's share price to reach $27.39 in the next year. This suggests a possible upside of 49.5% from the stock's current price.
View analysts price targets for AGL
or view top-rated stocks among Wall Street analysts.

How have AGL shares performed in 2023?

agilon health's stock was trading at $16.14 on January 1st, 2023. Since then, AGL shares have increased by 13.5% and is now trading at $18.32.
View the best growth stocks for 2023 here
.

Are investors shorting agilon health?

agilon health saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 40,190,000 shares, an increase of 10.5% from the August 15th total of 36,380,000 shares. Based on an average daily trading volume, of 2,640,000 shares, the short-interest ratio is presently 15.2 days. Approximately 13.3% of the company's stock are sold short.
View agilon health's Short Interest
.

When is agilon health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our AGL earnings forecast
.

How were agilon health's earnings last quarter?

agilon health, inc. (NYSE:AGL) announced its quarterly earnings data on Thursday, August, 3rd. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.03. The company had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.11 billion. agilon health had a negative net margin of 2.39% and a negative trailing twelve-month return on equity of 8.57%.

What guidance has agilon health issued on next quarter's earnings?

agilon health updated its third quarter 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.13 billion-$1.14 billion, compared to the consensus revenue estimate of $1.10 billion.

When did agilon health IPO?

(AGL) raised $1 billion in an initial public offering on Thursday, April 15th 2021. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

What is agilon health's stock symbol?

agilon health trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGL."

Who are agilon health's major shareholders?

agilon health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Clayton Dubilier & Rice LLC (24.11%), Capital World Investors (12.66%), Capital Research Global Investors (3.75%), BlackRock Inc. (3.19%), Capital International Investors (2.32%) and Rock Springs Capital Management LP (2.04%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Clay Richards, Glenn Sobotka, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias, Timothy Gertsch and Veeral Desai.
View institutional ownership trends
.

How do I buy shares of agilon health?

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is agilon health's stock price today?

One share of AGL stock can currently be purchased for approximately $18.32.

How much money does agilon health make?

agilon health (NYSE:AGL) has a market capitalization of $7.43 billion and generates $2.71 billion in revenue each year. The company earns $-106,550,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis.

How many employees does agilon health have?

The company employs 747 workers across the globe.

How can I contact agilon health?

The official website for the company is agilonhealth.com. The company can be reached via phone at 562-256-3800 or via email at investor.relations@agilonhealth.com.

This page (NYSE:AGL) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -